| Targeting SARS-CoV-2 M3CLpro by HCV NS3/4a Inhibitors: In Silico Modeling and In Vitro Screening A Manandhar, BE Blass, DJ Colussi, I Almi, M Abou-Gharbia, ML Klein, ... Journal of chemical information and modeling 61 (2), 1020-1032, 2021 | 28 | 2021 |
| QSAR investigations and structure-based virtual screening on a series of nitrobenzoxadiazole derivatives targeting human glutathione-S-transferases I Almi, S Belaidi, E Zerroug, M Alloui, RB Said, R Linguerri, M Hochlaf Journal of Molecular Structure 1211, 128015, 2020 | 18 | 2020 |
| Chemical reactivity, drug-likeness and structure activity/property relationship studies of 2, 1, 3-benzoxadiazole derivatives as anti-cancer activity I Almi, S Belaidi, N Melkemi, D Bouzidi Journal of Bionanoscience 12 (1), 49-57, 2018 | 12 | 2018 |
| Targeting SARS-CoV-2 M3CLpro by HCV NS3/4a Inhibitors A Manandhar, BE Blass, DJ Colussi, I Almi, M Abou-Gharbia, ML Klein, ... Silico, 2021 | 3 | 2021 |
| Contribution to drug design through computational studies ofseveral series of bioactive heterocyclic molecules I Almi Université de mohamed kheider biskra, 2021 | | 2021 |
